Masimo (MASI) Income towards Parent Company (2009 - 2026)
Masimo's (MASI) quarterly Income towards Parent Company came in at $800000.0 in Q2 2026, up 100.37% year-on-year from $399267.1 in Q2 2025, and down 87.5% quarter-over-quarter from $6.4 million in Q1 2026.
Masimo (MASI) Income towards Parent Company (2009 - 2026) Analysis & Trends
Masimo's Income towards Parent Company history runs 18 years deep, the most recent figure standing at $800000.0 for Q2 2026.
- On a quarterly basis, Income towards Parent Company rose 100.37% year-over-year to $800000.0 in Q2 2026; TTM through Apr 2026 was -$140.5 million, a 73.28% increase from a year earlier, with the FY2026 full-year figure at -$359.2 million, down 11.87% from the prior year.
- Income towards Parent Company eased to $800000.0 in Q2 2026 per MASI's latest filing, from $6.4 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at $60.1 million in Q4 2023 and bottomed at -$284.6 million in Q4 2024.
- The 5-year median for Income towards Parent Company is $8.5 million (2023), against an average of -$20.5 million.
- Biggest YoY gain for Income towards Parent Company was 172.73% in 2025; the steepest drop was 1550.76% in 2025.
- Year by year, Income towards Parent Company stood at $40.9 million in 2022, then soared by 46.94% to $60.1 million in 2023, then sank by 573.54% to -$284.6 million in 2024, then soared by 45.85% to -$154.1 million in 2025, then soared by 100.52% to $800000.0 in 2026.
- Per Business Quant, the three latest MASI Income towards Parent Company figures stand at $800000.0 (Q2 2026), $6.4 million (Q1 2026), and -$154.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 800,000.00 |
| Jan 3, 2026 | 6.40 Mn |
| Sep 27, 2025 | -154.10 Mn |
| Jun 28, 2025 | 6.40 Mn |
| Mar 29, 2025 | -217.90 Mn |
| Dec 28, 2024 | -284.60 Mn |
| Sep 28, 2024 | -14.50 Mn |
| Jun 29, 2024 | -8.80 Mn |
| Mar 30, 2024 | -13.20 Mn |
| Dec 30, 2023 | 60.10 Mn |
| Sep 30, 2023 | 10.60 Mn |
| Jul 1, 2023 | 15.70 Mn |
| Apr 1, 2023 | 21.30 Mn |
| Dec 31, 2022 | 40.90 Mn |
| Oct 1, 2022 | 37.90 Mn |
| Jul 2, 2022 | 18.10 Mn |
| Apr 2, 2022 | 46.60 Mn |
| Jan 1, 2022 | 59.97 Mn |
| Oct 2, 2021 | 57.80 Mn |
| Jul 3, 2021 | 50.20 Mn |